Emergent BioSolutions (NYSE:EBS) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Emergent BioSolutions missed estimated earnings by 155.65%, reporting an EPS of $-3.17 versus an estimate of $-1.24.
Revenue was down $142.40 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.35 which was followed by a 11.57% drop in the share price the next day.
Here's a look at Emergent BioSolutions's past performance:
To track all earnings releases for Emergent BioSolutions visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
